Race, Obesity and Enteroinsular Axis in Adolescents

青少年的种族、肥胖和肠岛轴

基本信息

项目摘要

DESCRIPTION (provided by applicant): My career goals are focused upon two concurrent diseases, childhood obesity and type 2 diabetes mellitus, affecting prominently adolescents of minority groups. Identifying new etiopathogenic mechanisms that explain the racial disparity and the potential influence of racial and lifestyle factors on predicting treatment outcomes are my long-term goals. With this focus, I am committed to patient-oriented translational research but I need to acquire specific skills that allow me to be more effective in this area. This award will allow me to accomplish these goals in the following way. I will: 1) enhance my statistical and epidemiological foundation; 2) develop skills in methodology, measurements, and analysis of epidemiological data; 3) develop the necessary knowledge in preventive medicine, pharmacoepidemiology and bioinformatics necessary for implementing interventional studies based on the experience gained in my training and the preliminary results of the proposed project. In obese African-American (AA) subjects, we have proposed that increased GLP-1 levels [marker of enteroinsular axis activity (EIA)] could promote adipogenesis and the development of comorbidities. It is still unclear whether these racial differences in EIA are determined by age, severity of overweight, differences in cardiorespiratory fitness (CRF) or autonomic nervous system (ANS) modulation. We will assess these three interrelated areas (EIA, CRF, and ANS modulation) in a biracial sample of wide-ranging overweight adolescents. In particular, we are interested in the relation between EIA activity and insulin dynamics as a potential mechanistic pathway to explain the increased prevalence of obesity, type 2 Diabetes Mellitus (T2DM) and Cardiovascular Disease (CVD) in AA youth. Therefore, we will determine the associations among EIA, CRF, glucose homeostasis, and risk factors for ICVD in adolescents. The results of this study can be translated into medical practice changes and may help to implement a more physiologically effective approach to obesity treatment in AA adolescents, in particular.
描述(由申请人提供): 我的职业目标集中在两种同时发生的疾病上,儿童肥胖症和2型糖尿病,这两种疾病对少数族裔青少年的影响尤为突出。确定新的致病机制来解释种族差异以及种族和生活方式因素对预测治疗结果的潜在影响是我的长期目标。有了这个重点,我致力于以患者为导向的翻译研究,但我需要获得特定的技能,使我在这一领域更有效。这个奖项将使我能够通过以下方式实现这些目标。我将:1)加强我的统计学和流行病学基础;2)发展流行病学数据的方法学、测量和分析方面的技能;3)根据我在培训中获得的经验和拟议项目的初步结果,发展实施干预研究所必需的预防医学、药物流行病学和生物信息学方面的知识。在肥胖的非裔美国人(AA)受试者中,我们提出增加GLP-1水平[肠岛轴活动(EIA)的标记物]可以促进脂肪生成和合并症的发展。目前尚不清楚EIA中的这些种族差异是由年龄、超重的严重程度、心肺功能(CRF)或自主神经系统(ANS)调节方面的差异决定的。我们将评估这三个相互关联的区域(EIA、CRF和ANS调节)在一个范围广泛的超重青少年的混血样本中。特别是,我们感兴趣的是EIA活性和胰岛素动力学之间的关系,作为解释肥胖、2型糖尿病(T2 DM)和心血管疾病(CVD)在AA青年中增加的潜在机制途径。因此,我们将确定EIA、CRF、葡萄糖稳态和青少年ICVD危险因素之间的关系。这项研究的结果可以转化为医疗实践的变化,可能会有所帮助 尤其是对再生障碍性贫血青少年实施更有效的生理治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PEDRO A VELASQUEZ-MIEYER其他文献

PEDRO A VELASQUEZ-MIEYER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PEDRO A VELASQUEZ-MIEYER', 18)}}的其他基金

SANDOSTATIN LAR DEPOT VS SALINE-CONTROL IN PEDIATRIC HYPOTHALAMIC OBESITY
善静定 LAR DEPOT 与盐水对照治疗小儿下丘脑肥胖症的比较
  • 批准号:
    7375436
  • 财政年份:
    2005
  • 资助金额:
    $ 13.49万
  • 项目类别:
Race, Obesity and Enteroinsular Axis in Adolescents
青少年的种族、肥胖和肠岛轴
  • 批准号:
    6863827
  • 财政年份:
    2005
  • 资助金额:
    $ 13.49万
  • 项目类别:
RACE, OBESITY AND ENTEROINSULAR AXIS IN ADOLESCENTS
青少年的种族、肥胖和肠岛轴
  • 批准号:
    7375433
  • 财政年份:
    2005
  • 资助金额:
    $ 13.49万
  • 项目类别:
Race, Obesity and Enteroinsular Axis in Adolescents
青少年的种族、肥胖和肠岛轴
  • 批准号:
    7456350
  • 财政年份:
    2005
  • 资助金额:
    $ 13.49万
  • 项目类别:
Race, Obesity and Enteroinsular Axis in Adolescents
青少年的种族、肥胖和肠岛轴
  • 批准号:
    7257223
  • 财政年份:
    2005
  • 资助金额:
    $ 13.49万
  • 项目类别:
ASSESSING THE IN-VIVO INTERACTION BETWEEN THE ENTEROINSULAR AXIS AND AUTONOMI
评估肠岛轴和自主神经之间的体内相互作用
  • 批准号:
    7375446
  • 财政年份:
    2005
  • 资助金额:
    $ 13.49万
  • 项目类别:
RACIAL DIFFERENCES IN THE IMPACT OF OVERWEIGHT IN ADOLESCENTS
青少年超重影响中的种族差异
  • 批准号:
    7206688
  • 财政年份:
    2004
  • 资助金额:
    $ 13.49万
  • 项目类别:
SANDOSTATIN LAR DEPOT VS SALINE-CONTROL IN PEDIATRIC HYPOTHALAMIC OBESITY
善静定 LAR DEPOT 与盐水对照治疗小儿下丘脑肥胖症的比较
  • 批准号:
    7206691
  • 财政年份:
    2004
  • 资助金额:
    $ 13.49万
  • 项目类别:
Multi-Center Study of Sandostatin LAR Depot in Patients w/ PIH and mod obesity
善宁 LAR 长效制剂治疗 PIH 和肥胖症患者的多中心研究
  • 批准号:
    7041756
  • 财政年份:
    2003
  • 资助金额:
    $ 13.49万
  • 项目类别:

相似海外基金

Can plant-derived extracellular vesicles improve outcomes in pregnancies complicated by maternal obesity?
植物源性细胞外囊泡能否改善妊娠合并肥胖的妊娠结局?
  • 批准号:
    MR/Y01362X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Research Grant
Strategy for improving clinical obesity therapeutics
改善临床肥胖治疗的策略
  • 批准号:
    MR/Y014707/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Research Grant
Investigating the mechanisms in sympathetic neurons that link sleep to obesity
研究交感神经元将睡眠与肥胖联系起来的机制
  • 批准号:
    BB/Y006488/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Research Grant
Evaluation of body measurement methods for children living with obesity
肥胖儿童体型测量方法评价
  • 批准号:
    MR/X03349X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Fellowship
Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you | BETTER4U
通过为您量身定制的生物学和行为干预措施来预防肥胖 |
  • 批准号:
    10093560
  • 财政年份:
    2023
  • 资助金额:
    $ 13.49万
  • 项目类别:
    EU-Funded
CIACCO-2024 (11th Annual symposium on Cytokines in Inflammation, Ageing, CanCer and Obesity)
CIACCO-2024(第11届炎症、衰老、癌症和肥胖中细胞因子年度研讨会)
  • 批准号:
    487821
  • 财政年份:
    2023
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Miscellaneous Programs
Does BMI miss the mark? Use of an abdominal obesity index in osteoarthritis
BMI 是否达标?
  • 批准号:
    499189
  • 财政年份:
    2023
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Operating Grants
Development and Validation of a Combined Risk Prediction Model for Childhood Obesity Using Cord Blood Genomics and Epigenomics
利用脐带血基因组学和表观基因组学开发和验证儿童肥胖联合风险预测模型
  • 批准号:
    23H02880
  • 财政年份:
    2023
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Developing public health policies for the out of home food sector to improve diet and reduce obesity
制定户外食品部门的公共卫生政策,以改善饮食和减少肥胖
  • 批准号:
    ES/W007932/1
  • 财政年份:
    2023
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Research Grant
Management of obesity-related inflammation by gut microbiota changes with exercise and dietary fiber supplementation
通过运动和膳食纤维补充改变肠道微生物群来管理肥胖相关炎症
  • 批准号:
    23K16738
  • 财政年份:
    2023
  • 资助金额:
    $ 13.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了